Announcements Trials
Browse Landscape

Phase

Phase NA 6Phase 2 6Phase 1 5Phase 1/2 1

Status

Recruiting 2Completed 2Terminated 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 2Tumor-Agnostic 1Gynecologic 1

Conditions

Rectal Neoplasms 1Ovarian Neoplasms 1Neoplasm Metastasis 1Liver Malignancy 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Ovarian Epithelial 1Carcinoma, Hepatocellular 1

Interventions

Cyclophosphamide 624pembrolizumab 500Paclitaxel 456Gemcitabine 438Carboplatin 435Cisplatin 418Radiotherapy 380fludarabine 365Nivolumab 340Docetaxel 277Bevacizumab 276Irinotecan 257Magnetic Resonance Spectroscopy 242Fluorouracil 228Dexamethasone 225Specimen Handling 221Capecitabine 218Rituximab 205Cytarabine 201Oxaliplatin 200Ipilimumab 199Temozolomide 197Biopsy 196fludarabine phosphate 194Etoposide 181Lenalidomide 176Doxorubicin 175Leucovorin 173Cetuximab 171Injections 170

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 1 × Yttrium-90 × Clear all
NCT05195710 2026-05-26

Preoperative Y-90 Radioembolization for Tumor Control and Future Liver Remnant Hypertrophy in Patients With Colorectal Liver Metastases

M.D. Anderson Cancer Center

Phase 1 Recruiting
50 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT04518748 2025-08-05

Combined Y-90 Selective Internal Radiation Therapy (Y-90 SIRT) and Stereotactic Body Radiation Therapy (SBRT) in Hepatic Malignancy.

University of Michigan Rogel Cancer Center

Phase 1 Recruiting
70 enrolled

Liver Malignancy

NCT04108481 2025-03-28

iRE-C

University of Iowa

Phase 1 Terminated
5 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00072410 2023-10-04

Radiolabeled Monoclonal Antibody in Treating Patients With Advanced Ovarian Epithelial Cancer

Ludwig Institute for Cancer Research

Phase 1 Completed
7 enrolled 7 charts
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT00846131 2016-09-15

Y-90 Alone or With Sorafenib for Pre-Transplant Hepatocellular Carcinoma

Northwestern University

Phase 1 Completed
24 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡